Breast cancer
Results
Other
This study aimed to find out how many women who had a high risk of developing breast cancer had considered using tamoxifen to prevent it.
The study was for women who had not been through the . The researchers also wanted to see if a substance in the blood called a can be used to find out which women may benefit from having tamoxifen.
Recruitment start: 2 May 2011
Recruitment end: 30 November 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gareth Evans
NIHR Clinical Research Network: Cancer
The Genesis Breast Cancer Prevention Appeal
NIHR Research for Patient Benefit (RfPB) programme
Last reviewed: 27 May 2015
CRUK internal database number: 8554